M15-913
ClinicalTrials.gov NCT03082209
Research payments
$834,821
Through program year 2020, $834,821 in research payments was reported against M15-913, across 113 payments, paid by AbbVie, Inc..
- Paid by
- AbbVie, Inc.
- ClinicalTrials.gov
- NCT03082209
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $294,226 | 53 |
| 2019 | Research | $540,595 | 60 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Drew Rasco San Antonio, TX Named on 31 payments
- Benedito Carneiro Filho Providence, RI Named on 24 payments
- Patricia Lo Russo Detroit, MI Named on 19 payments
- Sameem Abedin Milwaukee, WI Named on 18 payments
- Mark Ratain Burr Ridge, IL Named on 9 payments
- Michael Reiter Stony Brook, NY Named on 3 payments
- Kevin Baker Stony Brook, NY Named on 3 payments
- Murtaza Bhuriwala Kingwood, TX Named on 2 payments
- Marina Konopleva Houston, TX Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.